Kaddoura R, Ibrahim M, Al-Amri M, Nair A, Alharafsheh A, Alyafei S
Front Med (Lausanne). 2024; 11:1326156.
PMID: 38449886
PMC: 10915025.
DOI: 10.3389/fmed.2024.1326156.
Mengual-Moreno E, Nava M, Manzano A, Ariza D, DMarco L, Castro A
Biomedicines. 2024; 12(2).
PMID: 38397885
PMC: 10887136.
DOI: 10.3390/biomedicines12020283.
Devi S, Pamreddy A, Narendra V
J Diabetes Metab Disord. 2023; 22(1):135-146.
PMID: 37250369
PMC: 10083065.
DOI: 10.1007/s40200-023-01207-3.
Paramythiotis D, Karlafti E, Veroplidou K, Fafouti M, Kaiafa G, Netta S
Diagnostics (Basel). 2023; 13(8).
PMID: 37189499
PMC: 10137519.
DOI: 10.3390/diagnostics13081398.
Khan S, Rizvi T, Sadiq W, Sattar S, Maroun R
Cureus. 2023; 15(1):e34022.
PMID: 36814742
PMC: 9939567.
DOI: 10.7759/cureus.34022.
Unusual case of propofol-related infusion syndrome complicating severe COVID-19 ARDS.
Babu V, Rojas P, Perez Del Nogal G, Garcia-Fernandez A
BMJ Case Rep. 2023; 16(2).
PMID: 36750301
PMC: 9906275.
DOI: 10.1136/bcr-2022-249456.
COVID-19 and the Pancreas: A Narrative Review.
Sinagra E, Shahini E, Crispino F, Macaione I, Guarnotta V, Marasa M
Life (Basel). 2022; 12(9).
PMID: 36143329
PMC: 9504204.
DOI: 10.3390/life12091292.
Safety profile of COVID-19 drugs in a real clinical setting.
Chiu M, Bhardwaj M, Sah S
Eur J Clin Pharmacol. 2022; 78(5):733-753.
PMID: 35088108
PMC: 8794611.
DOI: 10.1007/s00228-021-03270-2.
The immunology and immunotherapy for COVID-19.
Liu Y, Zhou X, Liu X, Jiang X
Expert Rev Mol Med. 2021; 23:e24.
PMID: 34915958
PMC: 8723987.
DOI: 10.1017/erm.2021.30.
Severe acquired hypertriglyceridemia following COVID-19.
Fijen L, Grefhorst A, Levels J, Cohn D
BMJ Case Rep. 2021; 14(11).
PMID: 34764129
PMC: 8587683.
DOI: 10.1136/bcr-2021-246698.
Acute pancreatitis due to severe hypertriglyceridemia in the COVID-19 era: The role of therapeutic plasma exchange.
Pavanello F, Colpo A, Tison T, Fabris R, De Silvestro G, Marson P
Transfus Apher Sci. 2021; 61(1):103292.
PMID: 34711519
PMC: 8516145.
DOI: 10.1016/j.transci.2021.103292.
Finding answers in lipid profile in COVID-19 patients.
Sampedro-Nunez M, Aguirre-Moreno N, Garcia-Fraile Fraile L, Jimenez-Blanco S, Knott-Torcal C, Sanz-Martin P
Endocrine. 2021; 74(3):443-454.
PMID: 34668172
PMC: 8525620.
DOI: 10.1007/s12020-021-02881-0.
Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database.
Kamath A, Acharya S, Rao R, Ullal S
Sci Rep. 2021; 11(1):18818.
PMID: 34552181
PMC: 8458491.
DOI: 10.1038/s41598-021-98325-w.
Acute Hypertriglyceridemia in Patients with COVID-19 Receiving Parenteral Nutrition.
Villa Lopez G, Valero Zanuy M, Gonzalez Barrios I, Maiz Jimenez M, Gomis Munoz P, Leon Sanz M
Nutrients. 2021; 13(7).
PMID: 34371797
PMC: 8308259.
DOI: 10.3390/nu13072287.
Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions.
Oikonomou K, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A
World J Clin Cases. 2021; 9(19):4918-4938.
PMID: 34307544
PMC: 8283616.
DOI: 10.12998/wjcc.v9.i19.4918.
Acute pancreatitis and COVID-19: A literature review.
Correia de Sa T, Soares C, Rocha M
World J Gastrointest Surg. 2021; 13(6):574-584.
PMID: 34194615
PMC: 8223706.
DOI: 10.4240/wjgs.v13.i6.574.
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
Lopez-Medrano F, Perez-Jacoiste Asin M, Fernandez-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G
Int J Infect Dis. 2021; 105:487-494.
PMID: 33647515
PMC: 7908857.
DOI: 10.1016/j.ijid.2021.02.099.
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.
Zuo Z, Wu T, Pan L, Zuo C, Hu Y, Luo X
Front Pharmacol. 2021; 11:583914.
PMID: 33643033
PMC: 7908061.
DOI: 10.3389/fphar.2020.583914.
Advances in immunotherapy for COVID-19: A comprehensive review.
Masoomikarimi M, Garmabi B, Alizadeh J, Kazemi E, Azari Jafari A, Mirmoeeni S
Int Immunopharmacol. 2021; 93:107409.
PMID: 33581501
PMC: 7826020.
DOI: 10.1016/j.intimp.2021.107409.
Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol.
Kovacevic M, Dube K, Lupi K, Szumita P, DeGrado J
Crit Care Explor. 2021; 3(1):e0330.
PMID: 33490957
PMC: 7808527.
DOI: 10.1097/CCE.0000000000000330.
